Literature DB >> 8997763

The disadvantage of being advantaged?--on a social gradient in excess mortality among alcohol abusers.

I Rossow1, A Amundsen.   

Abstract

Do alcohol abusers from upper social classes have a more elevated excess mortality than alcohol abusers from lower social classes? This question was empirically assessed by analyses on data from a 40-year prospective study of more than 40,000 Norwegian conscripts on whom data on social class (i.e. educational level), alcohol abuse (admission to treatment) and cause specific mortality before the age of 60 years were available. The results demonstrated a social gradient in excess mortality: relative risk of premature death was 2.7 among those with the lowest educational level (primary school only) increasing to 6.2 among those with the highest educational level at conscription (grammar school). Among the alcohol abusers the risk of premature death, was slightly, but not significantly higher among those highly educated as compared to those with less education. Thus, alcohol abuse was not only found to elevate the individual's risk of premature death, but it also appeared to outweigh the advantages of those more socially privileged with respect to health and mortality. The question as to whether social class differences in selection to treatment could account for the observed social gradient in excess mortality is focused in the discussion.

Entities:  

Mesh:

Year:  1996        PMID: 8997763

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  2 in total

1.  What underlies the high alcohol related mortality of the disadvantaged: high morbidity or poor survival?

Authors:  P Mäkelä; I Keskimäki; S Koskinen
Journal:  J Epidemiol Community Health       Date:  2003-12       Impact factor: 3.710

Review 2.  Causal mechanisms proposed for the alcohol harm paradox-a systematic review.

Authors:  Jennifer Boyd; Olivia Sexton; Colin Angus; Petra Meier; Robin C Purshouse; John Holmes
Journal:  Addiction       Date:  2021-05-25       Impact factor: 7.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.